Csf p-tau₁₈₁/tau ratio as biomarker for TDP pathology in frontotemporal dementia

References

• Seelaar H, Rohrer JD, Pijnenburg YAL, Fox NC, van Swieten JC. Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review. J Neurol Neurosurg Psychiatry. 2011;82:476–86.
   PubMed Web of Science ®Google Scholar
• Lomen-Hoerth C, Anderson T, Miller B. The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology. 2002;59:1077–9.
   PubMed Web of Science ®Google Scholar
• Murphy JM, Henry RG, Langmore S, Kramer JH, Miller BL, Lomen-Hoerth C. Continuum of frontal lobe impairment in amyotrophic lateral sclerosis. Arch Neurol. 2007;64:530–4.
   PubMedGoogle Scholar
• Rascovsky K, Rohrer JD, Hodges JR, Knopman D, Mendez MF, Kramer JH, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134:2456–77.
   PubMed Web of Science ®Google Scholar
• Rohrer JD, Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76: 1006–14.
   Google Scholar
• Kertesz A, McMonagle P, Blair M, Davidson W, Munoz DG. The evolution and pathology of frontotemporal dementia. Brain. 2005;128:1996–2005.
   PubMed Web of Science ®Google Scholar
• Mackenzie IRA, Neumann M, Bigio EH, Cairns NJ, Alafuzoff I, Kril J, et al. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol. 2010;119:1–4.
   PubMed Web of Science ®Google Scholar
• Foster NL, Wilhelmsen K, Sima AA, Jones MZ, d’Amato CJ, Gilman S. Frontotemporal dementia and Parkinsonism linked to chromosome 17: a consensus conference. Ann Neurol. 1997;41:706–15.
   PubMed Web of Science ®Google Scholar
• Rollinson S, Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature. 2006;442:916–9.
   Google Scholar
• Cruts M, Gijselinck I, van der Zee J, Engelborghs S, Wils H, Pirici D, et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature. 2006;442:920–4.
   PubMed Web of Science ®Google Scholar
• Kabashi E, Valdmanis PN, Dion P, Spiegelman D, McConkey BJ, Velde CV, et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet. 2008;40:572–4.
   PubMed Web of Science ®Google Scholar
• Yuan Z, Becker EBE, Merlo P, Yamada T, DiBacco S, Konishi Y, et al. Activation of FOXO1 by Cdk1 in Cycling Cells and Postmitotic Neurons. Science. 2008;319:1665–8.
   PubMed Web of Science ®Google Scholar
• Dejesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, et al. Expanded GGGGCC Hexanucleotide Repeat in Non-coding Region of C9orf72 Causes Chromosome 9p-Linked FTD and ALS. Neuron. 2011; 72:245–56.
   PubMed Web of Science ®Google Scholar
• Rollinson S, Renton AE, Majounie E, Waite A, Simón-Sánchez J, Gibbs JR, et al. A Hexanucleotide Repeat Expansion in C9orf72 Is the Cause of Chromosome 9p21-Linked ALS-FTD. Neuron. 2011;72:257–68.
   Google Scholar
• Josephs KA, Petersen RC, Knopman DS, Boeve BF, Whitwell JL, Duffy JR, et al. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology. 2006;66:41–8.
   PubMed Web of Science ®Google Scholar
• Shi J, Shaw CL, Plessis D, Richardson AMT, Bailey KL, Julien C, et al. Histopathological changes underlying frontotemporal lobar degeneration with clinicopathological correlation. Acta Neuropathol. 2005;110:501–12.
   PubMed Web of Science ®Google Scholar
• Forman MS, Farmer J, Johnson JK, Clark CM, Arnold SE, Coslett HB, et al. Frontotemporal dementia: clinicopathological correlations. Ann Neurol. 2006;59:952–62.
   PubMed Web of Science ®Google Scholar
• Josephs KA, Whitwell JL, Jack CR, Parisi JE, Dickson DW. Frontotemporal lobar degeneration without lobar atrophy. Arch Neurol. 2006;63:1632–8.
   PubMedGoogle Scholar
• McMillan CT, Irwin DJ, Avants BB, Powers J, Cook PA, Toledo JB, et al. White matter imaging helps dissociate tau from TDP-43 in frontotemporal lobar degeneration. J Neurol Neurosurg Psychiatry. 2013;84:949–55.
   PubMed Web of Science ®Google Scholar
• Kim EJ, Rabinovici GD, Seeley WW, Halabi C, Shu H, Weiner M, et al. Patterns of MRI atrophy in tau-positive and ubiquitin-positive frontotemporal lobar degeneration. J Neurol Neurosurg Psychiatry. 2007;78:1375–8.
   PubMed Web of Science ®Google Scholar
• Josephs KA, Whitwell JL, Dickson DW, Boeve BF, Knopman DS, Petersen RC, et al. Voxel based morphometry in autopsy proven PSP and CBD. Neurobiol Aging. 2008;29:280–9.
   PubMed Web of Science ®Google Scholar
• Caso F, Mandelli ML, Henry M, Gesierich B. In vivo signatures of non-fluent/agrammatic primary progressive aphasia caused by FTLD pathology. Neurology. 2013;82:239–47.
   Google Scholar
• Hu WT, Watts K, Grossman M, Glass J, Lah JJ, Hales C, et al. Reduced CSF p-Tau181 to Tau ratio is a biomarker for FTLD-TDP. Neurology. 2013;81:1945–52.
   PubMed Web of Science ®Google Scholar
• Grossman M, Elman L, McCluskey L, McMillan CT, Boller A, Powers J, et al. Phosphorylated Tau as a Candidate Biomarker for Amyotrophic Lateral Sclerosis. JAMA Neurol. 2014;71:442–8.
   PubMed Web of Science ®Google Scholar
• Borroni B, Padovani A, Agosti C, Premi E, Cerini C, Cosseddu M, et al. The FTLD-modified Clinical Dementia Rating scale is a reliable tool for defining disease severity in frontotemporal lobar degeneration: evidence from a brain SPECT study. Eur J Neurol. 2010;17:703–7.
   PubMed Web of Science ®Google Scholar
• Premi E, Padovani A, Garibotto V, Alberici A, Paghera B, Giubbini R, et al. Nature versus nurture in frontotemporal lobar degeneration: the interaction of genetic background and education on brain damage. Dement Geriatr Cogn Disord. 2012;33:372–8.
   Google Scholar
• Borroni B, Padovani A, Benussi A, Ferrari F, Archetti S. Prevalence of cerebrospinal fluid Alzheimer disease-like pattern in atypical dementias. Advances in Alzheimer’s Disease. 2012;01:45–50.
   Google Scholar
• Knopman DS, Boeve BF, Parisi JE, Dickson DW, Smith GE, Ivnik RJ, et al. Ante mortem diagnosis of frontotemporal lobar degeneration. Ann Neurol. 2005;57:480–8.
   PubMed Web of Science ®Google Scholar
• Josephs KA. Frontotemporal dementia and related disorders: deciphering the enigma. Ann Neurol. 2008;64: 4–14.
   PubMed Web of Science ®Google Scholar
• Grossman M. Primary progressive aphasia: clinicopathological correlations. Nat Rev Neurol. 2010;6:88–97.
   PubMed Web of Science ®Google Scholar
• Padovani A, Borroni B, Gardoni F, Parnetti L, Magno L, Malinverno M, et al. Pattern of Tau forms in CSF is altered in progressive supranuclear palsy. Neurobiol Aging. 2009; 30:34–40.
   Google Scholar
• Borroni B, Padovani A, Malinverno M, Gardoni F, Alberici A, Parnetti L, et al. Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy. Neurology. 2008;71:1796–803.
   PubMed Web of Science ®Google Scholar